Abstract
We investigate the effect of school closure and subsequent reopening on the transmission of COVID-19, by considering Denmark, Norway, Sweden, and German states as case studies. By comparing the growth rates in daily hospitalisations or confirmed cases under different interventions, we provide evidence that school closures contribute to a reduction in the growth rate approximately 7 days after implementation. Limited school attendance, such as older students sitting exams or the partial return of younger year groups, does not appear to significantly affect community transmission. In countries where community transmission is generally low, such as Denmark or Norway, a large-scale reopening of schools while controlling or suppressing the epidemic appears feasible. However, school reopening can contribute to statistically significant increases in the growth rate in countries like Germany, where community transmission is relatively high. In all regions, a combination of low classroom occupancy and robust test-and-trace measures were in place. Our findings underscore the need for a cautious evaluation of reopening strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
HS and LP are funded by the Wellcome Trust and the Royal Society (grant 202562/Z/16/Z). FS is funded by the CIHR 2019 Novel Coronavirus (COVID-19) rapid research program. LP and FS are also supported by the UKRI through the JUNIPER modelling consortium (grant number MR/V038613/1). SG was supported by the Medical Research Council (Unit programme number MC UU 00002/11). JS and TF are funded through the Department for Health and Social Care grant in aid funding to Public Health England.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No specific ethics approval required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* joseph.shingleton{at}phe.gov.uk, helena.stage{at}manchester.ac.uk
Data Availability
All data used in the production of this work, can be found in the electronic supplementary material.
